Drug discovery has always been a time-consuming process. On an average, it takes 10-15 years and capital investments worth USD 4-10 billion to commercially launch a drug.

The global quantum computing market size is estimated to grow from USD 0.39 billion in 2024 to USD 1.63 billion by 2035, representing a CAGR of 13.86% during the forecast period till 2035.

It involves various processes such as target identification, validation, hit generation, hit to lead and lead optimization. Whereas development include optimization and formulation, clinical trials and final approval by authorized regulatory. However, despite of the advances in technology drug discovery process is still considered to be complex, expensive and lengthy. In order to address such concerns, drug developers are shifting their focus from traditional techniques to the use of novel discovery techniques. Presently, Quantum Computing has emerged as one of the prominent technologies.  The use of quantum computing has shown to help the drug developers in selecting potential lead candidates, having the desired physiochemical and pharmacokinetic properties, without having to conduct extensive screening procedures.

Quantum computing is a process, using law of quantum mechanics to solve large and complex problems in short span as compared to the computer aided drug discovery.  Currently, there are several quantum computing related approaches that are being used in the drug discovery process alone, such as structure-based drug design, fragment-based drug discovery and ligand-based drug discovery. The predictive power of quantum computing has proven to reduce the complexity, cost and time investment in drug discovery procedure by allowing researchers to bypass the random screening of billions of molecules in a short span of time

Distribution by Drug Discovery Service Offered

Target Identification / Validation

Hit Generation / Lead Identification

Lead Optimization

Distribution by Therapeutic Area

Cardiovascular Disorders

CNS Disorders

Dermatological Disorders

Endocrine Disorders

Gastrointestinal Disorders

Immunological Disorders

Infectious Diseases

Musculoskeletal Disorders

Oncological Disorders

Respiratory Disorders

Others

Key Geographical Regions

North America

Europe

Asia

MENA

Latin America

Rest of the World

Advantages of Quantum Computing in Drug Discovery:

• Faster Computation: It has a potential to perform computation at much higher rate. It is useful in target identification by enabling its deeper exploration of complex therapeutic area


• Cost Benefits: It has capability to allow cost effective analysis. It reduces the expensive lab testing by enhancing the screening accuracy of the targeted molecules.


• Facilitate the design of Clinical Trials: Quantum computing accelerate the design of clinical trial which. further helps in building virtual patients for clinical trials. This potentially reduces time of trials and increasing quality.


• Reduce discovery timeline: It accelerates the high throughput screening of multiple targeted molecules at a given time hence reducing the discovery timeline of drugs.


• Possible modeling of complex molecules: It helps molecular modelers to achieve new level of accuracy by modeling complex molecule interaction. It focuses on different target area and increases the affinity towards the targeted molecules.

Hence, it can be concluded that players offering services for quantum computing in drug discovery have now become an integral part of the pharmaceutical industry. Furthermore, considering the various active initiatives being undertaken by players based in this domain, we are led to believe that the opportunity for stakeholders in this niche, upcoming, industry is likely to grow at an exponential pace in the foreseen future.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Sales@rootsanalysis.com